clinical medicine News
-
Improving Medicine with Philosophy of Science
Philosophy addresses issues that can’t be settled by facts alone, and the philosophy of science is the application of this approach to the domain of science [1]. More than ever we need philosophical analysis and perspective to realize the benefits of science, particularly in the realm of health and healing. We recently attended the Philosophy of Science Association’s 26th biennial ...
By Echobio, LLC
-
HistoSonics Receives Approval To Begin European #HOPE4LIVER Clinical Study
HistoSonics announced today that it has received approval to initiate the company’s second European clinical trial of its new platform technology, which is designed to use the science of histotripsy to mechanically destroy targeted liver tumors, from outside of the body. The study, similar to HistoSonics’ recent FDA approved #HOPE4LIVER U.S. Study, is a multi-center, open label, ...
By HistoSonics
-
Haymarket Media Group expands US Board as it enters its next phase of rapid growth
Today Haymarket Media, Inc CEO Lee Maniscalco announced three new appointments to its Haymarket Media Inc Board. The Board welcomes on board Professor and Chairman of Surgery at Fox Chase Cancer, Robert G. Uzzo, MD, MBA, and national thought-leader in digital health transformation, Daniel T. Garrett, who will join existing non-executive Board Member, Melissa Boone. At the same time, Michael ...
-
Reetoo made a wonderful appearance at CACLP
From March 28 to March 30, 2021, the 18th China International Laboratory Medicine and Blood Transfusion Instruments and Reagent Expo was successfully held at Chongqing International Expo Center. Reetoo Biotech carries 7 major types of specimen series products, including vaginal secretion detector, sperm quality analyzer, automatic chromosome microscopic image scanning system, automatic urine ...
-
A Message from Spectrum Dynamics Medical: Update to COVID-19
Healthcare providers managing patients during the COVID-19 pandemic are confronting new and unique operational and business challenges. During this time, our focus is on supporting you and the safety and well-being of our employees. We know our sales and technical support teams are vitally important to support you, as well as the communities where we serve. Many of you continue to provide nuclear ...
-
Regor announces the first patient dosed in the U.S. in the Phase II clinical trial for RGT-075, a novel small molecule GLP-1R agonist
Regor Therapeutics Group, a clinical-stage biotech company focusing on immunology, oncology, and metabolic disorders, announced today that the first patient has been dosed in the Phase II clinical trial of the Company’s novel oral small molecule GLP-1 receptor agonist RGT-075 in the U.S. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a well-characterized class of hypoglycemic ...
-
SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019
SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that Murthy Simhambhatla, Ph.D., President and Chief Executive Officer, is scheduled to present at the 13th annual Canaccord Genuity Medical Technologies & Diagnostics Forum, being held November 21, 2019 in New York, New York. Event: Canaccord Genuity ...
-
Regor announces China NMPA approval of the IND for RGT-264 phosphate tablet, a potent and selective HPK1 inhibitor
Regor Therapeutics, a clinical-stage biotech company, announced today the Investigational New Drug (IND) Application for RGT-264 phosphate tablet, a small molecular selective hematopoietic progenitor kinase (HPK1) inhibitor has been approved by the National Medical Products Administration (NMPA) of China. RGT-264 phosphate tablet is a highly potent and selective HPK1 inhibitor. HPK1 kinase ...
-
SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019
SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that Murthy Simhambhatla, Ph.D., President and Chief Executive Officer, is scheduled to present at the 13th annual Canaccord Genuity Medical Technologies & Diagnostics Forum, being held November 21, 2019 in New York, New York. Event: Canaccord Genuity ...
-
Showcase
Empatica partnering with U.S. Army MRDC to deploy COVID-19 early detection wearable
BOSTON, Nov. 6, 2020 /PRNewswire/ -- Empatica has been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to deploy a wearable and algorithm that enable the early and pre-symptomatic detection of COVID-19. The project's focus is on protecting the health of the general population by preventing outbreaks via early detection and alerting. Empatica's Aura algorithm gives a ...
-
ANX ROBOTICA RECEIVES FDA DE-NOVO CLASSIFICATION FOR FIRST-OF-ITS-KIND NAVICAM™ REMOTE-CONTROLLED CAPSULE ENDOSCOPY SYSTEM FOR THE STOMACH
Plano, Texas (June 4, 2020) AnX Robotica Corporation today announced it has been granted by the Food and Drug Administration (FDA) De-Novo classification for its NaviCamTM Magnetically Controlled Capsule Endoscopy (MCCE) System. The first-of-its-kind system allows complete, real-time visualization of the stomach utilizing a pill-sized capsule containing a camera and is remote-controlled by the ...
By AnX Robotica
-
Setpoint Medical announces oral presentation of results from U.S. Pilot Study in Rheumatoid Arthritis Patients at American College of Rheumatology (ACR) Annual Meeting 2019
SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that results from its U.S. pilot Investigational Device Exemption (IDE) study in rheumatoid arthritis (RA) have been accepted for oral presentation at the American College of Rheumatology (ACR) Annual Meeting, being held November 8-13, 2019 in Atlanta, GA. The ...
-
The desperate need for medical isotopes
With preparations underway for manufacturing the MIFTEC Z-pinch (ZEBRA) Fusion Medical Isotope Generators, US Nuclear Corp. (OTCBB: UCLE) is one step closer to ending the dire worldwide shortage of medical isotopes. The federal government is so desperate to find a domestic, stable supply of medical isotopes that they recently awarded over $60 million in funding to 8 projects/companies working ...
-
Regor and Lilly Enter into Strategic Collaboration to Discover and Develop Novel Therapies for Metabolic Disorders
Eli Lilly and Company (NYSE: LLY) and Regor Therapeutics Group have entered into a multi-year research collaboration and licensing agreement to discover, develop and commercialize novel therapies for metabolic disorders. Under the terms of the agreement, Lilly will have a license to select Regor intellectual property with an option to extend the license. Lilly will be responsible for clinical ...
-
Injectsense adds experts to Medical advisory board
Injectsense, Inc. an innovative medical device firm that develops sensor-enabled digital health systems to measure therapy effectiveness, announced today additional members of its medical advisory board. The board, which includes world renowned specialists and surgeons in the ophthalmic field, provides valuable feedback on device requirements, procedures, risk mitigation, and regulatory issues. ...
-
SetPoint Medical CEO Murthy Simhambhatla Named to AIMBE College of Fellows
SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that the American Institute for Biological and Medical Engineering (AIMBE) has elected Murthy Simhambhatla, PhD, to the AIMBE College of Fellows for “outstanding contributions as a medical technology innovator and business leader, advancing health for ...
-
Training and consultancy for Analyse-it
Our focus at Analyse-it has always been on the development and improvement of our software. While we provide extensive help, tutorials, and technical support for Analyse-it, one area we do not cover is training and consultancy. As many of you will know we are based in England in the United Kingdom, and providing training and consultancy is often done better locally, in-person. Instead we ...
-
SetPoint Medical Appoints Amy Derosier as Vice President of Clinical Affairs
SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapies for chronic autoimmune diseases, today announced the appointment of Amy Derosier as Vice President of Clinical Affairs. “Amy’s extensive experience in successfully designing and executing clinical trials for novel medical devices complements that of our CMO, Dr. David Chernoff, who has extensive ...
-
SetPoint Medical Receives IDE Approval for U.S. Pivotal Trial to Study its Bioelectronic Platform in Rheumatoid Arthritis Patients
SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to study its proprietary bioelectronic platform in patients with rheumatoid arthritis (RA). The multicenter, double-blind, randomized, sham ...
-
Employee Spotlight: Joana Murad Mabaera PhD
Joana Murad Mabaera, Executive Director of R&D Expertise: Cellular Therapies and Molecular Biomarkers What are your professional interests & in what ways does Celdara help you engage those interests? My core professional interest is translational science. At Celdara Medical, I help build the foundation for the development of early-stage innovation into life-changing treatment options. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you